Source: S&P Global

Advanco: Parabellum buys serialized drug tracking systems company Advanco

Parabellum Investments (UK) acquired Brussels-based anti-counterfeit drug specialist Advanco, marking the middle-market private equity firm's foray into the drug market.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Alf Goebel's photo - CEO of Advanco

CEO

Alf Goebel

CEO Approval Rating

82/100

Read more